Alnylam Pharmaceuticals I...

NASDAQ: ALNY · Real-Time Price · USD
449.02
6.29 (1.42%)
At close: Aug 15, 2025, 3:59 PM
448.00
-0.23%
After-hours: Aug 15, 2025, 05:30 PM EDT

Alnylam Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-278.16M -440.24M -1.13B -852.82M
Depreciation & Amortization
56.67M 97.03M 85.55M 89.69M
Stock-Based Compensation
272.08M 221.68M 230.65M 165.72M
Other Working Capital
-232.22M -509K -147.59M -122.85M
Other Non-Cash Items
261.94M 214.93M 309.24M 174.24M
Deferred Income Tax
-106.76M n/a n/a -55.7M
Change in Working Capital
-214.08M 10.76M -35.55M -162.82M
Operating Cash Flow
-8.31M 104.16M -541.27M -641.69M
Capital Expenditures
-34.28M -62.21M -72.06M -76.37M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-1.71B -1.82B -1.98B -1.66B
Sales Maturities Of Investments
1.57B 1.55B 2.23B 1.46B
Other Investing Acitivies
57.76M -4.44M -13.19M -4.36M
Investing Cash Flow
-116.84M -336.35M 169.35M -273.3M
Debt Repayment
n/a n/a 254M 500M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-8.79M 24.67M -87.61M 500.85M
Financial Cash Flow
294.16M 172.13M 425.75M 1.25B
Net Cash Flow
153.77M -53.67M 46.4M 323.11M
Free Cash Flow
-42.59M 41.95M -613.33M -718.07M